{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:32:06Z","timestamp":1788503526603,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN272201300028C"],"award-info":[{"award-number":["HHSN272201300028C"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.vaccine.2019.08.071","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T17:47:25Z","timestamp":1567705645000},"page":"6162-6170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and heterologous H5N1 lethal challenge"],"prefix":"10.1016","volume":"37","author":[{"given":"Douglas","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Streatfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamala","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Fattom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10127","key":"10.1016\/j.vaccine.2019.08.071_b0005","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2019.08.071_b0010","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.pcl.2017.03.007","article-title":"Influenza: a global perspective","volume":"64","author":"Rotrosen","year":"2017","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.vaccine.2019.08.071_b0015","unstructured":"WHO. Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO; 2019. <http:\/\/wwwwhoint\/influenza\/human_animal_interface\/H5N1_cumulative_table_archives\/en\/>."},{"issue":"1","key":"10.1016\/j.vaccine.2019.08.071_b0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.virusres.2013.05.006","article-title":"H5N1 vaccines in humans","volume":"178","author":"Baz","year":"2013","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.vaccine.2019.08.071_b0025","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/viro.2002.1625","article-title":"Mechanism of neutralization of influenza virus infectivity by antibodies","volume":"302","author":"Knossow","year":"2002","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2019.08.071_b0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2288-10-18","article-title":"Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model","volume":"10","author":"Coudeville","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.vaccine.2019.08.071_b0035","first-page":"63","article-title":"Haemagglutination-inhibiting antibody to influenza virus","volume":"115","author":"de Jong","year":"2003","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2019.08.071_b0040","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu Rev Biochem."},{"issue":"4","key":"10.1016\/j.vaccine.2019.08.071_b0045","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1750-2659.2011.00242.x","article-title":"Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1\u20133, 2010","volume":"5","author":"Haaheim","year":"2011","journal-title":"Influenza Other Respir Viruses"},{"issue":"6044","key":"10.1016\/j.vaccine.2019.08.071_b0050","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1210724","article-title":"Biochemistry catching a moving target","volume":"333","author":"Wang","year":"2011","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.vaccine.2019.08.071_b0055","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.vaccine.2019.02.002","article-title":"Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge","volume":"37","author":"Wang","year":"2019","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2019.08.071_b0060","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.3390\/v4113227","volume":"4","author":"Chichester","year":"2012","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.vaccine.2019.08.071_b0065","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.vaccine.2008.11.108","article-title":"Plant-derived hemagglutinin protects ferrets against challenge infection with the A\/Indonesia\/05\/05 strain of avian influenza","volume":"27","author":"Shoji","year":"2009","journal-title":"Vaccine"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2019.08.071_b0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4161\/hv.7.0.14561","article-title":"Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza","volume":"7","author":"Shoji","year":"2011","journal-title":"Hum Vaccin."},{"issue":"7","key":"10.1016\/j.vaccine.2019.08.071_b0075","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4161\/hv.6.7.11818","article-title":"Efficacy, immunogenicity and stability of a novel intranasal Nanoemulsion-adjuvanted influenza vaccine in a murine model","volume":"6","author":"Hamouda","year":"2010","journal-title":"Hum Vaccines"},{"issue":"7","key":"10.1016\/j.vaccine.2019.08.071_b0080","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1128\/CVI.00035-11","article-title":"Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant","volume":"18","author":"Hamouda","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.08.071_b0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.vaccine.2011.10.094","article-title":"Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens","volume":"30","author":"Stanberry","year":"2012","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2019.08.071_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002954","article-title":"Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine","volume":"3","author":"Makidon","year":"2008","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.vaccine.2019.08.071_b0095","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.4049\/jimmunol.1301424","article-title":"Distinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant","volume":"192","author":"Bielinska","year":"2014","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2019.08.071_b0100","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1023\/A:1006496308160","article-title":"pGreen: a versatile and flexible binary Ti vector for Agrobacterium-mediated plant transformation","volume":"42","author":"Hellens","year":"2000","journal-title":"Plant Mol Biol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2019.08.071_b0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0166-0934(89)90004-9","article-title":"Assessment of signs of influenza illness in the ferret model","volume":"24","author":"Reuman","year":"1989","journal-title":"J Virol Methods."},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2019.08.071_b0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virusres.2004.02.019","article-title":"Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A\/Duck\/Singapore\/97 vaccine","volume":"103","author":"Stephenson","year":"2004","journal-title":"Virus Res"},{"issue":"3","key":"10.1016\/j.vaccine.2019.08.071_b0115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/jmv.10408","article-title":"Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin","volume":"70","author":"Stephenson","year":"2003","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.08.071_b0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcv.2008.04.013","article-title":"Testing human sera for antibodies against avian influenza viruses: Horse RBC hemagglutination inhibition vs. microneutralization assays","volume":"43","author":"Kayali","year":"2008","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2019.08.071_b0125","unstructured":"Webster R, Cox N, Stohr K. WHO manual on animal influenza diagnosis and surveillance. WHO Global Influenza Program; 2002."},{"issue":"12","key":"10.1016\/j.vaccine.2019.08.071_b0130","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/infdis\/jir661","article-title":"Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection","volume":"204","author":"Ohmit","year":"2011","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2019.08.071_b0135","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr Opin Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.08.071_b0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat Struct Mol Biol"},{"issue":"12","key":"10.1016\/j.vaccine.2019.08.071_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"Throsby","year":"2008","journal-title":"PLoS One"},{"issue":"5924","key":"10.1016\/j.vaccine.2019.08.071_b0150","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.vaccine.2019.08.071_b0155","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1128\/IAI.00070-07","article-title":"Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against bacillus anthracis spore challenge","volume":"75","author":"Bielinska","year":"2007","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2019.08.071_b0160","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/aid.2007.0148","article-title":"Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV Type 1 isolates","volume":"24","author":"Bielinska","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7","key":"10.1016\/j.vaccine.2019.08.071_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021823","article-title":"A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease","volume":"6","author":"Lindell","year":"2011","journal-title":"PLoS One."},{"key":"10.1016\/j.vaccine.2019.08.071_b0170","article-title":"Influenza and memory T Cells: how to awake the force","author":"Spitaels","year":"201644","journal-title":"Vaccines (Basel)"},{"issue":"5753","key":"10.1016\/j.vaccine.2019.08.071_b0175","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1126\/science.1118948","article-title":"Divergent immunoglobulin G subclass activity through selective Fc receptor binding","volume":"310","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"issue":"4804","key":"10.1016\/j.vaccine.2019.08.071_b0180","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.3107127","article-title":"Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production","volume":"236","author":"Snapper","year":"1987","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2019.08.071_b0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1615\/CritRevImmunol.v30.i2.60","article-title":"Induction of Th17 cellular immunity with a novel nanoemulsion adjuvant","volume":"30","author":"Bielinska","year":"2010","journal-title":"Crit Rev Immunol."},{"issue":"6","key":"10.1016\/j.vaccine.2019.08.071_b0190","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cytogfr.2010.11.002","article-title":"The role of Th17 cytokines in primary mucosal immunity","volume":"21","author":"Kolls","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6241","key":"10.1016\/j.vaccine.2019.08.071_b0195","doi-asserted-by":"crossref","first-page":"aaa8205","DOI":"10.1126\/science.aaa8205","article-title":"VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells","volume":"348","author":"Stary","year":"2015","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2019.08.071_b0200","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.coi.2012.03.014","article-title":"Vaccines against mucosal infections","volume":"24","author":"Holmgren","year":"2012","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2019.08.071_b0205","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1128\/JVI.75.11.5141-5150.2001","article-title":"Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection","volume":"75","author":"Tumpey","year":"2001","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.08.071_b0210","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41423-018-0192-y","article-title":"Tissue-resident lymphocytes: from adaptive to innate immunity","volume":"16","author":"Sun","year":"2019","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2019.08.071_b0215","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1002\/eji.201142346","article-title":"Nanoemulsion mucosal adjuvant uniquely activates cytokine production by nasal ciliated epithelium and induces dendritic cell trafficking: Immunity to infection","volume":"42","author":"Makidon","year":"2012","journal-title":"Eur J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19311478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19311478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:34:30Z","timestamp":1759401270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19311478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":43,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0264410X19311478"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and heterologous H5N1 lethal challenge","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}